ORTINLABSS

Ortin Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2020.

Ortin Laboratories Limited has informed the Exchange regarding Board meeting held on January 23, 2021.

Ortin Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

Members of the Exchange are hereby informed that the trading in Equity Shares of Ortin Laboratories Limited shall be suspended w.e.f. January 12, 2021 on account of Scheme of Arrangement - Demerger and Capital Reduction

Ortin Laboratories Limited has informed the Exchange regarding Resignation of Mrs T Uma Sangeetha as Non- Executive Independent Director of the company w.e.f. January 01, 2021.

Ortin Laboratories Limited has informed the Exchange that Record date for the purpose of Merger/HiveOff is 13-Jan-2021.

Ortin Laboratories Limited has informed the Exchange regarding Board meeting held on January 01, 2021.

Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Ortin Laboratories Limited has informed the Exchange regarding 'Update on Scheme of Arrangement between Ortin Laboratories Limited (Demerged Company) and Vineet Laboratories Limited (Resulting Company) (Receipt of NCLT order)'.

Ortin Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on December 29, 2020. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.

Ortin Laboratories Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 23-Dec-2020 to 29-Dec-2020 for the purpose of Annual general Meeting.

Significant movement in price has been observed in Ortin Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Ortin Laboratories Limited has submitted their response.

Significant movement in price has been observed in Ortin Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

Ortin Laboratories Limited has informed the Exchange about related Party Transactions

Ortin Laboratories Limited has informed the Exchange regarding Board meeting held on December 05, 2020.

Ortin Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2020.

Ortin Laboratories Limited has informed the Exchange regarding Appointment of Mr Murali Krishna Rayaprolu as Non- Executive Independent Director of the company w.e.f. October 23, 2020.

Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Ortin Laboratories Limited has submitted to the Exchange, the financial results for the period ended June 30, 2020.

Ortin Laboratories Limited has informed the Exchange about related Party Transactions for the year ended 31.03.2020

Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Ortin Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2020.

Ortin Laboratories Limited has informed the Exchange regarding Appointment of Mr Nitesh Kumar Sharma as Company Secretary & Compliance Officer of the company w.e.f. July 24, 2020.

Ortin Laboratories Limited has informed the Exchange regarding 'Certificate u/r 74 of SEBI (DP) Regulations, 2018'.

Ortin Laboratories Limited has informed the Exchange regarding 'Disclosure of material impact of COVID-19 pandemic on theCompany Reg.'.

Ortin Laboratories Limited has informed the Exchange regarding 'Compliance Certificate under Regulation 74(5) of SEBI (Depositories & Participants)Regulations, 2018'.

Ortin Laboratories Limited has informed the Exchange regarding 'Disclosures under Regulation 31(4) of SEBI (Substantial Acquisition of Shares & Takeovers)Regulations, 2011'.

Promoters of Ortin Laboratories Limited has informed the Exchange regarding disclosure under reguation 30(2) OF SEBI (SAST) Regukation, 2011

Significant movement in price has been observed in Ortin Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Ortin Laboratories Limited has submitted their response.

Significant movement in price has been observed in Ortin Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Ortin Laboratories Limited has informed the Exchange regarding Resignation of Mr K Pradyumna Teja as Non- Executive Independent Director of the company w.e.f. March 04, 2020.

Ortin Laboratories Limited has informed the Exchange regarding 'Voting Results and Scrutinizers Report of Hon ble NCLT Convened Meetings of the Equity Shareholders and Sundry Creditors of Ortin Laboratories Limited (the "Company')'.

Ortin Laboratories Limited has submitted the Exchange a copy Srutinizers report of Court Convened General Meeting held on February 26, 2020. Further, the company has informed the Exchange regarding voting results.

Ortin Laboratories Limited has informed the Exchange regarding 'Outcome of Hon ble Tribunal convened meeting of Sundry Creditors held on 26.02.2020 at 10:30 a.m.'.

Ortin Laboratories Limited has informed the Exchange regarding Proceedings of Court Convened General Meeting held on February 26, 2020

Ortin Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2019.

Ortin Laboratories Limited has informed the Exchange regarding 'copies of noticepublished in Business Standard (English)and Nava Telangana (Telugu) newspapers regarding dispatch of Notice of the Hon ble National Company Law Tribunal Convened Meeting of Sundry Creditors scheduled to be held on Wednesday, 26th January, 2020 at 10:30 A.M.'.

Ortin Laboratories Limited has informed the Exchange regarding 'Copies of noticepublished in Business Standard (English)and Nava Telangana (Telugu) newspapers regarding dispatch of Notice and E-Voting Facility for the Hon ble National Company Law Tribunal Convened Meeting of Equity Shareholders scheduled to be held on Wednesday, 26th January, 2020 at 11:00 A.M.'.

Ortin Laboratories Limited has informed the Exchange regarding 'Notice of Honble National Company Law Tribunal convened meeting of Sundry Creditors to be held on Wednesday,26th February, 2020 at 10:30 A.M.'.

Ortin Laboratories Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on February 26, 2020

Ortin Laboratories Limited has informed the Exchange regarding 'mendment in the appointed date from 01.04.2017 to 01.04.2020 in the scheme of arrangement between Ortin Laboratories Limited (Demerged Company) and Vineet Laboratories Limited (Resulting Company)'.

Significant movement in price has been observed in Ortin Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Ortin Laboratories Limited has submitted their response.

Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Significant movement in price has been observed in Ortin Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

Ortin Laboratories Limited has submitted to the Exchange a copy of disclosures of related party transactions on a consolidated basis, pursuant to Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, in the format specified in the relevant accounting standards for the year ended September 30, 2019.

Ortin Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2019.

Ortin Laboratories Limited has informed the Exchange regarding Resignation of Ms Sharvari Swapnil Shinde as Company Secretary & Compliance Officer of the company w.e.f. October 21, 2019.

Ortin Laboratories Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2019. Further, the company has informed the Exchange regarding voting results.

Ortin Laboratories Limited has informed the Exchange regarding 'Outcome of AGM held on 30.09.2019'.